Doris Lang‐Loidolt

Nasal IL-5 levels determine the response to anti–IL-5 treatment in patients with nasal polyps

Philippe Gevaert, Doris Lang‐Loidolt, Andreas Lackner et al. · Journal of Allergy and Clinical Immunology · 2006 · 431 citations · Full text

Clinical Immunology, Nasal Polyps, Immunodeficiencies +6

Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation

G Hofmann, Thomas Bauernhofer, Peter Krippl et al. · BMC Cancer · 2006 · 181 citations · Full text

Nasal mucus proteomic changes reflect altered immune responses and epithelial permeability in patients with allergic rhinitis

Peter Valentin Tomazic, Ruth Birner‐Gruenberger, Anita Leitner et al. · Journal of Allergy and Clinical Immunology · 2013 · 79 citations

Inflammation, Inflammatory Lung Disease, Allergy +9

Development of Molecular Methods for Identification of <i>Schizophyllum commune</i> from Clinical Samples

Walter Buzina, Doris Lang‐Loidolt, H Braun et al. · Journal of Clinical Microbiology · 2001 · 72 citations · Full text

EP4 receptor stimulation down-regulates human eosinophil function

Petra Luschnig-Schratl, Eva M. Sturm, Viktória Kónya et al. · Cellular and Molecular Life Sciences · 2011 · 57 citations · Full text